Cambridge Investment Research Advisors, Inc. Vivos Therapeutics, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$1.63 - $3.63 $31,295 - $69,696
-19,200 Closed
0 $0
Q4 2021

Feb 03, 2022
BUY
$2.25 - $4.11 $16,200 - $29,592
7,200 Added 60.0%
19,200 $0
Q3 2021

Nov 02, 2021
SELL
$2.71 - $5.9 $69,243 - $150,750
-25,551 Reduced 68.04%
12,000 $0
Q2 2021

Aug 10, 2021
BUY
$4.83 - $9.67 $181,371 - $363,118
37,551 New
37,551 $0

About Vivos Therapeutics, Inc.

VVOS Quotes by TradingView
  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email